Patrícia Silva is a Research Assistant at the Oral Pathology and Rehabilitation Research Unit (UNIPRO, IUCS-CESPU) and an Invited Auxiliar Professor of Human Body Morphology and Functions at the University Institute of Health Sciences (IUCS) of CESPU. She graduated in Pathological, Cytological, and Thanatological Anatomy (CESPU) in 2008 and completed a Master's in Molecular Biology Techniques and Cytomics in Health Science (CESPU) in 2011. From 2013 to 2017, she pursued her Ph.D. in Biomedical Sciences at the Department of Biomedical Sciences and Medicine at the University of Algarve, where she investigated the function, regulation, and therapeutic implications of the Spindle Assembly Checkpoint (SAC) mechanism (FEBS Lett. 2014 Aug 25;588(17):3265-73; FEBS Lett. 2015 Nov 30;589(23):3588-94; Cancer Lett. 2017 May 28;394:33-42). Her Ph.D. research was conducted at the Centre for Biomedical Research (CBMR, Ualg) in collaboration with CESPU. Presently, her research interests revolve around the clinical relevance of mitosis regulation and the development of strategies to induce cancer cells death or enhance their sensitivity to current anti-mitotic agents (Oral Dis. 2019 Jul;25(5):1291-1301; Pharmaceutics. 2020 Dec 6;12(12):1186; Sci Rep. 2021 Feb 18;11(1):4139; Pharmaceutics. 2021 Jul 2;13(7):1011.; Curr Cancer Drug Targets. 2021;21(5):401-415; Pharmaceutics 14 6 (2022): 1209.). She has published 39 articles in international peer-reviewed (ISI) journals, mostly in Q1. Additionally, she has authored/co-authored 29 invited/selected talks at national and international meetings, been involved in 22 projects with competitive funding (FCT, Norte2020, CESPU), and co-supervised 20 MSc and graduated students and 2 PhD students.
Patrícia Silva is a Research Assistant at the Oral Pathology and Rehabilitation Research Unit (UNIPRO, IUCS-CESPU) and an Invited Auxiliar Professor of Human Body Morphology and Functions at the University Institute of Health Sciences (IUCS) of CESPU. She graduated in Pathological, Cytological, and Thanatological Anatomy (CESPU) in 2008 and completed a Master's in Molecular Biology Techniques and Cytomics in Health Science (CESPU) in 2011. From 2013 to 2017, she pursued her Ph.D. in Biomedical Sciences at the Department of Biomedical Sciences and Medicine at the University of Algarve, where she investigated the function, regulation, and therapeutic implications of the Spindle Assembly Checkpoint (SAC) mechanism (FEBS Lett. 2014 Aug 25;588(17):3265-73; FEBS Lett. 2015 Nov 30;589(23):3588-94; Cancer Lett. 2017 May 28;394:33-42). Her Ph.D. research was conducted at the Centre for Biomedical Research (CBMR, Ualg) in collaboration with CESPU. Presently, her research interests revolve around the clinical relevance of mitosis regulation and the development of strategies to induce cancer cells death or enhance their sensitivity to current anti-mitotic agents (Oral Dis. 2019 Jul;25(5):1291-1301; Pharmaceutics. 2020 Dec 6;12(12):1186; Sci Rep. 2021 Feb 18;11(1):4139; Pharmaceutics. 2021 Jul 2;13(7):1011.; Curr Cancer Drug Targets. 2021;21(5):401-415; Pharmaceutics 14 6 (2022): 1209.). She has published 39 articles in international peer-reviewed (ISI) journals, mostly in Q1. Additionally, she has authored/co-authored 29 invited/selected talks at national and international meetings, been involved in 22 projects with competitive funding (FCT, Norte2020, CESPU), and co-supervised 20 MSc and graduated students and 2 PhD students.
Research Assistant